Valuation: AtriCure, Inc.

Market Cap 173.6Cr 151.85Cr 140.06Cr 129.36Cr 245.45Cr 17TCr 249.58Cr 1.67TCr 657.17Cr 8.16TCr 651.81Cr 637.62Cr 28TCr P/E 2026 *
747x
P/E 2027 * 101x
Enterprise Value 158Cr 138.2Cr 127.47Cr 117.73Cr 223.4Cr 15TCr 227.15Cr 1.52TCr 598.12Cr 7.42TCr 593.24Cr 580.33Cr 26TCr EV / Sales 2026 *
2.61x
EV / Sales 2027 * 2.22x
Free-Float
96.14%
Yield 2026 *
-
Yield 2027 * -
1 day-0.81%
1 week+7.83%
Current month+22.52%
1 month+20.66%
3 months+21.43%
6 months-17.32%
Current year-13.35%
1 week 31.57
Extreme 31.57
34.81
1 month 26.81
Extreme 26.81
34.81
Current year 25.36
Extreme 25.36
43.18
1 year 25.36
Extreme 25.36
43.18
3 years 18.94
Extreme 18.94
59.61
5 years 18.94
Extreme 18.94
89.18
10 years 13.45
Extreme 13.45
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 54 01/03/2017
Director TitleAgeSince
Director/Board Member 62 04/12/2019
Director/Board Member 55 02/11/2012
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Chief Operating Officer

527 0.0010%
30/06Free

Chief Executive Officer

636 0.0013%
30/06Free

General Counsel

636 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%+7.83%+11.59%-31.45% 173.6Cr
-0.50%-1.54%-28.85%-12.62% 16TCr
+1.80%+0.82%-6.73%-3.92% 11TCr
+0.32%+2.34%+2.79%+57.04% 5.9TCr
+0.79%-3.68%+39.99%+54.50% 5.17TCr
+0.72%-3.88%-13.66%-41.41% 4.19TCr
+0.47%-4.98% - - 3.47TCr
+2.66%+5.21%-10.09%-42.88% 2.89TCr
-1.10%-3.29%+55.70%-5.76% 2.5TCr
0.00%-1.01%-5.28%-3.57% 2.11TCr
Average +0.44%-0.14%+5.05%-3.34% 5.35TCr
Weighted average by Cap. +0.50%-0.90%-5.54%+0.91%

Financials

2026 *2027 *
Net sales 60Cr 53Cr 49Cr 45Cr 86Cr 5.77TCr 87Cr 583.16Cr 229.01Cr 2.84TCr 227.14Cr 222.2Cr 9.77TCr 68Cr 59Cr 55Cr 51Cr 96Cr 6.47TCr 98Cr 654.04Cr 256.84Cr 3.19TCr 254.75Cr 249.2Cr 11TCr
Net income 26.6L 23.27L 21.46L 19.82L 37.61L 25Cr 38.24L 2.56Cr 1.01Cr 12Cr 99.88L 97.7L 43Cr 1.75Cr 1.53Cr 1.41Cr 1.3Cr 2.47Cr 166.75Cr 2.51Cr 17Cr 6.62Cr 82Cr 6.56Cr 6.42Cr 282.4Cr
Net Debt -16Cr -14Cr -13Cr -12Cr -22Cr -1.49TCr -22Cr -150.37Cr -59Cr -732.9Cr -59Cr -57Cr -2.52TCr -23Cr -20Cr -19Cr -17Cr -33Cr -2.22TCr -33Cr -223.9Cr -88Cr -1.09TCr -87Cr -85Cr -3.75TCr
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
10/26/10 $34.28 -0.81% 5,63,626
09/26/09 $34.56 +2.67% 9,40,668
08/26/08 $33.66 +2.62% 8,01,386
07/26/07 $32.80 +1.27% 7,14,720
06/26/06 $32.39 +1.89% 8,37,120
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
34.28USD
Average target price
47.00USD
Spread / Average Target
+37.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock